Bench-top Bioreactor
Multifors 2
Bench-top Bioreactor
Multifors 2
Manage multiple bioreactor vessels in parallel while mitigating risks during scale-up.
Increase efficiency during process development and characterization by configuring your Multifors® 2 bench-top bioreactor with the same sensor technology as your production bioreactor systems.Advantages
The magnetic drive system allows for maximum headplate ports and ergonomics while minimizing the contamination risk and wear on components; capable of 1600 RPM operation for extended continuous batches.
Save time, space, and resources with optimized parallel bioprocessing, operating up to 6 Multifors® bioreactor vessels from one touchscreen control. With a small footprint and robust housing, you can make the most of your bench space.
Be prepared to scale-up from the bench using the same sensor technologies as the larger scale bioreactors, delivering comparable data. Optional PAT tools are available to offer a straightforward way of preparing for later production at bench or pilot-scale bioreactors.
The magnetic drive system allows for maximum headplate ports and ergonomics while minimizing the contamination risk and wear on components; capable of 1600 RPM operation for extended continuous batches.
Save time, space, and resources with optimized parallel bioprocessing, operating up to 6 Multifors® bioreactor vessels from one touchscreen control. With a small footprint and robust housing, you can make the most of your bench space.
Be prepared to scale-up from the bench using the same sensor technologies as the larger scale bioreactors, delivering comparable data. Optional PAT tools are available to offer a straightforward way of preparing for later production at bench or pilot-scale bioreactors.
Automate your process development data
Further optimize your process development through automation. eve®, a web-based bioprocess platform software easily integrates with your bioreactors, regardless of the manufacturer, so you can more efficiently control, monitor, and analyze your data.
A guide for biotech beginners
Download this eBook for basic concepts, recipes, and strategies for bioprocesses involving cell culture and microorganisms.
Product specifications
- Vessel sizes (and working volumes): 400 mL (115 - 250 mL), 750 mL (180 - 500 mL), and 1400 mL (320 - 1000 mL)
- Small footprint: 45 x 38 cm (18 x 15 in) with integrated pumps, reagent holders, and mass flow controller (MFC)
- Glass vessels available in total volume range from 0.4 L to 1 L
Product downloads
Fill out a quick form to gain access to the document
Related publications
All publicationsResearchers at the University of Tartu, Institute of Bioengineering used adaptive laboratory evolution (ALE) to evolve Clostridium autoethanogenum into a faster-growing, yeast extract-free strain named LAbrini. This strain demonstrates improved robustness and performance in continuous bioreactor cultures, offering new potential for sustainable production of renewable chemicals and fuels.
In a new study, published on Springer Link, researchers produced a more stable and cost-effective interleukin-1 receptor antagonist (IL-1Ra) using Aspergillus oryzae. This alternative to E. coli-expressed IL-1Ra offers improved stability and bioactivity, making it a promising option for industrial-scale production. Explore the full findings and implications for therapeutic manufacturing.
A study conducted by LanzaTech, published in Biotechnology for Biofuels, explores how Clostridium autoethanogenum (an acetogenic bacterium) adapts to various hydrogen ratios in its feedstock. The focus of this study is to enhance carbon capture efficiency with a spotlight on CO₂ conversion. This research unveils the metabolic adaptations of C. autoethanogenum and paves the way for innovative bioengineering strategies to maximize CO₂ conversion in industrial applications.
Researchers at the University of Tartu, Institute of Bioengineering used adaptive laboratory evolution (ALE) to evolve Clostridium autoethanogenum into a faster-growing, yeast extract-free strain named LAbrini. This strain demonstrates improved robustness and performance in continuous bioreactor cultures, offering new potential for sustainable production of renewable chemicals and fuels.
In a new study, published on Springer Link, researchers produced a more stable and cost-effective interleukin-1 receptor antagonist (IL-1Ra) using Aspergillus oryzae. This alternative to E. coli-expressed IL-1Ra offers improved stability and bioactivity, making it a promising option for industrial-scale production. Explore the full findings and implications for therapeutic manufacturing.
A study conducted by LanzaTech, published in Biotechnology for Biofuels, explores how Clostridium autoethanogenum (an acetogenic bacterium) adapts to various hydrogen ratios in its feedstock. The focus of this study is to enhance carbon capture efficiency with a spotlight on CO₂ conversion. This research unveils the metabolic adaptations of C. autoethanogenum and paves the way for innovative bioengineering strategies to maximize CO₂ conversion in industrial applications.
Customer voices
Dr. Emma Allen-VercoeAssociate Professor at the University of Guelph, Canada
Dr. Ben J. GuPrincipal Scientist and Lab Head, Innate Phagocytosis Laboratory
Related articles
See allAs demand for sustainable food sources surges, Daisy Lab is revolutionizing dairy production with precision fermentation technology. By using INFORS HT bioreactors, this New Zealand-based startup is producing animal-free milk proteins like whey and casein. Discover how the innovative process at Daisy Labs, now set to scale with EPA approval, is paving the way for a more sustainable future in dairy.
Discover how INFORS HT bioreactors and services have supported bioprocess education and research at Universiti Sains Malaysia (USM). Joo Shun TAN (陈裕声), Associate Professor, shares insights on leveraging Minifors, Multifors, and Techfors bioreactors to enhance teaching, research, and scale-up processes.
Zara Summers, Chief Science Officer at LanzaTech, a Biotech Company, vividly articulates the company goal to reduce fossil fuel consumption and instead, recycle carbon, that is already above ground to create necessities: "We want it so every child in the world can pick up a crayon and color the sky and have that crayon that they pick be blue. Right? And today that is not the reality for every kid around the world."
As demand for sustainable food sources surges, Daisy Lab is revolutionizing dairy production with precision fermentation technology. By using INFORS HT bioreactors, this New Zealand-based startup is producing animal-free milk proteins like whey and casein. Discover how the innovative process at Daisy Labs, now set to scale with EPA approval, is paving the way for a more sustainable future in dairy.
Discover how INFORS HT bioreactors and services have supported bioprocess education and research at Universiti Sains Malaysia (USM). Joo Shun TAN (陈裕声), Associate Professor, shares insights on leveraging Minifors, Multifors, and Techfors bioreactors to enhance teaching, research, and scale-up processes.
Zara Summers, Chief Science Officer at LanzaTech, a Biotech Company, vividly articulates the company goal to reduce fossil fuel consumption and instead, recycle carbon, that is already above ground to create necessities: "We want it so every child in the world can pick up a crayon and color the sky and have that crayon that they pick be blue. Right? And today that is not the reality for every kid around the world."
Ideal offerings to further optimize your bioprocess workflow
Maintain optimal performance and longevity in your bioreactors with a range of services and support.
The eve® software integrates workflows, devices, bioprocess information and big data in a user-friendly web-based platform.
Bring flexible universal control to your process development in larger bench-top volumes.
Maintain optimal performance and longevity in your bioreactors with a range of services and support.
The eve® software integrates workflows, devices, bioprocess information and big data in a user-friendly web-based platform.
Bring flexible universal control to your process development in larger bench-top volumes.